Briefing: STAT+: A biotech turns to Apple Watch to study its Parkinson’s drug
Strategic angle: In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and more
International reporting with regional context and cross-border impact.
Strategic angle: In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and more
Strategic angle: U.S. dealers saw the potent coupe and the AMG G63 Cabriolet.
Strategic angle: Uber plans to invest in Rivian to deploy a fleet of autonomous robotaxis by 2031.
Strategic angle: UNM's RESEP provides essential support for uranium miners facing radiation exposure.
The Taliban government claims airstrikes by Pakistan's military targeted a drug rehabilitation hospital, resulting in civilian casualties.
Strategic angle: New strength training guidelines emphasize that doing any resistance training is what truly matters.
Strategic angle: Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
Strategic angle: The former counter-terrorism head resigned on Tuesday over the war with Iran, saying the country posed 'no imminent threat' to the US.
Strategic angle: This Utility Company Trading In A Buy Zone Offers A Bright Future
The company faces penalties for failing to comply with environmental regulations.
Strategic angle: A look at the financial performance of Lithium Americas in the fourth quarter.
Strategic angle: Two people have died since the epidemic came to light at the weekend, centered on the University of Kent in southeastern Canterbury and a local nightclub popular with students.
Strategic angle: EU leaders are hesitant to engage in the Middle East conflict while facing rising energy costs.
Strategic angle: Britain has rolled out the red carpet for Nigerian President Bola Tinubu, marking the first state visit by a Nigerian leader in 37 years.
Strategic angle: Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure?
Strategic angle: Iran's Gulf neighbors have said attacks on energy infrastructure won't "go unanswered," but, so far, they have not hit back at Iran. That stance could change soon.
Strategic angle: An overview of the significant updates in the Nuclear Power Facilities Draft by Dentons.
Strategic angle: Military users express concerns over the potential removal of Anthropic's AI tool.
Strategic angle: A new study reveals how plants adapt to extreme drought conditions in the American Southwest.
Strategic angle: Autism experts plan to convene in Washington Thursday to propose a research agenda at odds with the one endorsed by the Trump Administration.